Zymeworks (ZYME) Cash from Investing Activities (2021 - 2026)

Zymeworks has reported Cash from Investing Activities for 6 years, with the latest figure at $70.0 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 474.28% year-over-year to $70.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.4 million (up 44.95% YoY) and the FY2025 annual result came in at $26.7 million, down 31.2% from the prior year.
• Cash from Investing Activities grew to $70.0 million in Q1 2026 per ZYME's latest filing, from $5.4 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $72.3 million in Q3 2024 and troughed at -$138.2 million in Q1 2023.
• A 5-year average of -$7.4 million and a median of -$6.2 million in 2024 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities tumbled 1088.21% in 2022, then surged 1129.3% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$22.1 million in 2022, then surged by 93.94% to -$1.3 million in 2023, then slumped by 364.77% to -$6.2 million in 2024, then jumped by 186.39% to $5.4 million in 2025, then soared by 1203.26% to $70.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $70.0 million, $5.4 million, and $368000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.